Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 2/2023

05.12.2022 | Research Article

Prioritizing patients for medication review by emergency department pharmacists: a multi-method study

verfasst von: Anna Birna Almarsdóttir, Romana Haq, Josefine Dalgaard Scheel Vandel Nørgaard

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Little is known about how pharmacists think and act in the situation when they need to prioritize patients without prioritization tools.

Aim

To understand how Emergency Department (ED) pharmacists prioritize patients for medication review.

Method

A multi-method study with pharmacists working in one ED in Denmark. At the start of the study, non-clinical prioritization rules had been implemented at the ED to ensure that medication histories were available quickly. Qualitative participant observations of all seven pharmacists who work at the ED were carried out. Semi-structured interviews with six of the pharmacists were held near in time to the observations. Observations for each pharmacists’ patients were analysed inductively looking for patterns and themes. The interviews were audiotaped, transcribed verbatim and analysed inductively.

Results

The interviews shed light on the kinds of considerations pharmacists processed when prioritizing patients and how they used the ground rules (as set out in the PDSA process). The observations supplemented these data by showing some notable differences between pharmacists’ prioritization procedures that linked to their clinical experience. The interviews highlighted the importance of collaboration with physicians and how pharmacists could be better integrated in the ward team.

Conclusion

Although the ward-established rules increased efficiency, they were handled differently by the pharmacists according to experience, and were not deemed helpful in detecting the clinically meaningful ED patients. A prioritization tool and sitting near to the physicians at the ward would enable pharmacists to become further integrated into patient care and improve prioritization of patients for medication reviews.
Literatur
1.
Zurück zum Zitat Buckley MS, Harinstein LM, Clark KB, et al. Impact of a clinical pharmacy admission medication reconciliation program on medication errors in “high-risk” patients. Ann Pharmacother. 2013;47(12):1599–610.CrossRefPubMed Buckley MS, Harinstein LM, Clark KB, et al. Impact of a clinical pharmacy admission medication reconciliation program on medication errors in “high-risk” patients. Ann Pharmacother. 2013;47(12):1599–610.CrossRefPubMed
2.
Zurück zum Zitat Lewis P. Right patient, right time, right pharmacist: the time for clinical prioritisation tools? Eur J Hosp Pharm. 2017;24:314. Lewis P. Right patient, right time, right pharmacist: the time for clinical prioritisation tools? Eur J Hosp Pharm. 2017;24:314.
3.
Zurück zum Zitat Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48(2):203–14.PubMed Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48(2):203–14.PubMed
4.
Zurück zum Zitat Fernandes O, Shojania KG. Medication reconciliation in the hospital: what, why, where, when, who and how. Healthc Q. 2012;15(special):42–9. Fernandes O, Shojania KG. Medication reconciliation in the hospital: what, why, where, when, who and how. Healthc Q. 2012;15(special):42–9.
5.
Zurück zum Zitat Corny J, Rajkumar A, Martin O, et al. A machine learning–based clinical decision support system to identify prescriptions with a high risk of medication error. J Am Med Inform Assoc. 2020;27(11):1688–94.CrossRefPubMedPubMedCentral Corny J, Rajkumar A, Martin O, et al. A machine learning–based clinical decision support system to identify prescriptions with a high risk of medication error. J Am Med Inform Assoc. 2020;27(11):1688–94.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Nguyen T-L, Leguelinel-Blache G, Kinowski J-M, et al. Improving medication safety: development and impact of a multivariate model-based strategy to target high-risk patients. PLoS ONE. 2017;12(2):e0171995.CrossRefPubMedPubMedCentral Nguyen T-L, Leguelinel-Blache G, Kinowski J-M, et al. Improving medication safety: development and impact of a multivariate model-based strategy to target high-risk patients. PLoS ONE. 2017;12(2):e0171995.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Martinbiancho JK, Zuckermann J, Mahmud SD, et al. Development of risk score to hospitalized patients for clinical pharmacy rationalization in a high complexity hospital. Lat Am J Pharm. 2011;30(7):1342–7. Martinbiancho JK, Zuckermann J, Mahmud SD, et al. Development of risk score to hospitalized patients for clinical pharmacy rationalization in a high complexity hospital. Lat Am J Pharm. 2011;30(7):1342–7.
8.
Zurück zum Zitat Geeson C, Wei L, Franklin BD. High-risk medicines associated with clinically relevant medication-related problems in UK hospitals: a prospective observational study. Br J Clin Pharmacol. 2020;86(1):165–9.CrossRefPubMed Geeson C, Wei L, Franklin BD. High-risk medicines associated with clinically relevant medication-related problems in UK hospitals: a prospective observational study. Br J Clin Pharmacol. 2020;86(1):165–9.CrossRefPubMed
9.
Zurück zum Zitat Abuzour AS, Hoad-Reddick G, Shahid M, et al. Patient prioritisation for hospital pharmacy services: current approaches in the UK. Eur J Hosp Pharm. 2021;28:e102–8.CrossRefPubMed Abuzour AS, Hoad-Reddick G, Shahid M, et al. Patient prioritisation for hospital pharmacy services: current approaches in the UK. Eur J Hosp Pharm. 2021;28:e102–8.CrossRefPubMed
10.
Zurück zum Zitat Alshakrah MA, Steinke DT, Tully MP, et al. Development of the adult complexity tool for pharmaceutical care (ACTPC) in hospital: a modified Delphi study. Res Social Adm Pharm. 2021;17(11):1907–22.CrossRefPubMed Alshakrah MA, Steinke DT, Tully MP, et al. Development of the adult complexity tool for pharmaceutical care (ACTPC) in hospital: a modified Delphi study. Res Social Adm Pharm. 2021;17(11):1907–22.CrossRefPubMed
11.
Zurück zum Zitat Falconer N, Nand S, Liow D, et al. Development of an electronic patient prioritization tool for clinical pharmacist interventions. Am J Health Syst Pharm. 2014;71(4):311–20.CrossRefPubMed Falconer N, Nand S, Liow D, et al. Development of an electronic patient prioritization tool for clinical pharmacist interventions. Am J Health Syst Pharm. 2014;71(4):311–20.CrossRefPubMed
12.
Zurück zum Zitat Geeson C, Wei L, Franklin BD. Development and performance evaluation of the medicines optimisation assessment tool (MOAT): a prognostic model to target hospital pharmacists’ input to prevent medication-related problems. BMJ Qual Saf. 2019;28(8):645–56.CrossRefPubMedPubMedCentral Geeson C, Wei L, Franklin BD. Development and performance evaluation of the medicines optimisation assessment tool (MOAT): a prognostic model to target hospital pharmacists’ input to prevent medication-related problems. BMJ Qual Saf. 2019;28(8):645–56.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Boeker EB, Ram K, Klopotowska JE, et al. An individual patient data meta-analysis on factors associated with adverse drug events in surgical and non-surgical inpatients. Br J Clin Pharmacol. 2015;79(4):548–57.CrossRefPubMed Boeker EB, Ram K, Klopotowska JE, et al. An individual patient data meta-analysis on factors associated with adverse drug events in surgical and non-surgical inpatients. Br J Clin Pharmacol. 2015;79(4):548–57.CrossRefPubMed
14.
Zurück zum Zitat Cornuault L, Mouchel V, Thi TTP, et al. Identification of variables influencing pharmaceutical interventions to improve medication review efficiency. Int J Clin Pharm. 2018;40(5):1175–9.CrossRefPubMed Cornuault L, Mouchel V, Thi TTP, et al. Identification of variables influencing pharmaceutical interventions to improve medication review efficiency. Int J Clin Pharm. 2018;40(5):1175–9.CrossRefPubMed
15.
Zurück zum Zitat Saedder EA, Brock B, Nielsen LP, et al. Identifying high-risk medication: a systematic literature review. Eur J Clin Pharmacol. 2014;70(6):637–45.CrossRefPubMed Saedder EA, Brock B, Nielsen LP, et al. Identifying high-risk medication: a systematic literature review. Eur J Clin Pharmacol. 2014;70(6):637–45.CrossRefPubMed
16.
Zurück zum Zitat Suggett E, Marriott J. Risk factors associated with the requirement for pharmaceutical intervention in the hospital setting: a systematic review of the literature. Drugs Real World Outcomes. 2016;3(3):241–63. Suggett E, Marriott J. Risk factors associated with the requirement for pharmaceutical intervention in the hospital setting: a systematic review of the literature. Drugs Real World Outcomes. 2016;3(3):241–63.
19.
Zurück zum Zitat Falconer N, Barras M, Cottrell N. How hospital pharmacists prioritise patients at high-risk for medication harm. Res Soc Adm Pharm. 2019;15(10):1266–73.CrossRef Falconer N, Barras M, Cottrell N. How hospital pharmacists prioritise patients at high-risk for medication harm. Res Soc Adm Pharm. 2019;15(10):1266–73.CrossRef
20.
Zurück zum Zitat Gibson D, Forlow J, Davison J. Staff perceptions and opinions on workload prioritisation practices in hospital pharmacy. Appl Res. 2019;91:17–22. Gibson D, Forlow J, Davison J. Staff perceptions and opinions on workload prioritisation practices in hospital pharmacy. Appl Res. 2019;91:17–22.
22.
Zurück zum Zitat Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88.CrossRefPubMed Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88.CrossRefPubMed
23.
Zurück zum Zitat Robertshawe BJ, McDermott LM, Harden B. Introduction of an electronic prioritisation tool for medicines reconciliation for maternity patients at Christchurch Women’s hospital. J Paediatr Child Health. 2018;54:107–107.CrossRef Robertshawe BJ, McDermott LM, Harden B. Introduction of an electronic prioritisation tool for medicines reconciliation for maternity patients at Christchurch Women’s hospital. J Paediatr Child Health. 2018;54:107–107.CrossRef
24.
Zurück zum Zitat Dodds L. Prioritising pharmaceutical care delivery at ward level: a resource for pharmacy managers working in inpatient settings. East South East Engl Spec Pharm Serv. 2011:1–23. Dodds L. Prioritising pharmaceutical care delivery at ward level: a resource for pharmacy managers working in inpatient settings. East South East Engl Spec Pharm Serv. 2011:1–23.
25.
Zurück zum Zitat Shane R, Gouveia W. The dilemma of establishing effective pharmacy staffing levels. Am J Health Syst Pharm. 2009;66(23):2103.CrossRefPubMed Shane R, Gouveia W. The dilemma of establishing effective pharmacy staffing levels. Am J Health Syst Pharm. 2009;66(23):2103.CrossRefPubMed
26.
Zurück zum Zitat Duncan P, Ridd MJ, McCahon D, et al. Barriers and enablers to collaborative working between GPs and pharmacists: a qualitative interview study. Br J Gen Pract. 2020;70(692):e155–63.CrossRefPubMedPubMedCentral Duncan P, Ridd MJ, McCahon D, et al. Barriers and enablers to collaborative working between GPs and pharmacists: a qualitative interview study. Br J Gen Pract. 2020;70(692):e155–63.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Blondal AB, Sporrong SK, Almarsdottir AB. Introducing pharmaceutical care to primary care in Iceland—an action research study. Pharm. 2017;5(2):23. Blondal AB, Sporrong SK, Almarsdottir AB. Introducing pharmaceutical care to primary care in Iceland—an action research study. Pharm. 2017;5(2):23.
28.
Zurück zum Zitat Rixon S, Braaf S, Williams A, et al. Pharmacists’ interprofessional communication about medications in specialty hospital settings. Health Commun. 2015;30(11):1065–75.CrossRefPubMed Rixon S, Braaf S, Williams A, et al. Pharmacists’ interprofessional communication about medications in specialty hospital settings. Health Commun. 2015;30(11):1065–75.CrossRefPubMed
29.
Zurück zum Zitat Wertheimer AI. The underutilised pharmacist. J Pharm Health Serv Res. 2018;9:77.CrossRef Wertheimer AI. The underutilised pharmacist. J Pharm Health Serv Res. 2018;9:77.CrossRef
30.
Zurück zum Zitat Malterud K. Qualitative research: standards, challenges, and guidelines. Lancet. 2001;358:483–8.CrossRefPubMed Malterud K. Qualitative research: standards, challenges, and guidelines. Lancet. 2001;358:483–8.CrossRefPubMed
Metadaten
Titel
Prioritizing patients for medication review by emergency department pharmacists: a multi-method study
verfasst von
Anna Birna Almarsdóttir
Romana Haq
Josefine Dalgaard Scheel Vandel Nørgaard
Publikationsdatum
05.12.2022
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 2/2023
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-022-01515-3

Weitere Artikel der Ausgabe 2/2023

International Journal of Clinical Pharmacy 2/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.